(Q48452025)

11 February 2018

title

Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra (English)

1 reference

11 February 2018

0 references

1 reference

1 reference

1 reference

1 reference

Fumiaki Mori

1

1 reference

11 February 2018

Makoto Nishie

2

1 reference

11 February 2018

Akiyoshi Kakita

3

1 reference

11 February 2018

Makoto Yoshimoto

4

1 reference

11 February 2018

Hitoshi Takahashi

5

1 reference

11 February 2018

Koichi Wakabayashi

6

1 reference

11 February 2018

publication date

1 August 2006

1 reference

11 February 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

11 February 2018

volume

65

1 reference

11 February 2018

issue

8

1 reference

11 February 2018

page(s)

808-815

1 reference

11 February 2018

Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups.

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Accumulation of phosphorylated alpha-synuclein in aging human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

alpha-Synuclein is phosphorylated in synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Neuropathology of the locus ceruleus: a semi-quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Contribution of somal Lewy bodies to neuronal death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

New pathologic observations in juvenile onset parkinsonism with dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Familial juvenile parkinsonism: clinical and pathologic study in a family

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

A quantitative investigation of the substantia nigra in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Involvement of Onuf's nucleus in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Could a loss of alpha-synuclein function put dopaminergic neurons at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000230520.47768.1A

10.1097/01.JNEN.0000230520.47768.1A

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

release_3e6xqvh7vvdsthtjbz52gopew4

Fatcat ID

0 references

1 reference

11 February 2018